High Vista Strategies LLC Repare Therapeutics Inc. Transaction History

High Vista Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.63 - $12.53 $2,442 - $3,545	283 Added 0.17%	165,173 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$12.5 - $18.13 $1.74 Million - $2.53 Million	-139,291 Reduced 45.79%	164,890 $2.43 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $1.75 Million - $2.36 Million	151,581 Added 99.33%	304,181 $3.69 Million
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $77,951 - $136,899	9,225 Added 6.43%	152,600 $2.14 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $1.14 Million - $2.19 Million	99,878 Added 229.62%	143,375 $2.04 Million
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $145,346 - $207,817	7,393 Added 20.48%	43,497 $917,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $928,233 - $1.27 Million	36,104 New	36,104 $947,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.